🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchTRIUMPH program (retatrutide) — my results so far Page 7

TRIUMPH program (retatrutide) — my results so far

BenResearch_OR Fri, Jan 31, 2025 at 9:18 PM 42 replies 1,987 viewsPage 7 of 9
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Feb 18, 2025 at 5:57 AM#31
TinaHashiRN said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

There is a second half to this that has not been said yet. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Last edited: Feb 18, 2025 at 11:57 AM
50 23lucas_SP_BR, lisa_labSD, adam_van and 47 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Feb 19, 2025 at 5:54 AM#32

Adding the numbers, since they settle part of this. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

1 24MikeFit_NJ
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Feb 20, 2025 at 5:50 AM#33

One thing that is still open after TinaHashiRN’s answer:

What did you change at the same time, and can you separate the two now?

2 0DataDave, Dr.GutHealth
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Feb 21, 2025 at 5:45 AM#34
NicoleRaleigh said:
Say what you would expect to see if you were wrong, before you look.

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

3 1JessicaM_2024, TomFromTexas, mike.trainer_LA
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Feb 22, 2025 at 5:40 AM#35
NicoleRaleigh said:
Say what you would expect to see if you were wrong, before you look.

Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.

Last edited: Feb 22, 2025 at 8:40 AM
4 2B12Beth, RickReta_CO, PharmHunterJen and 1 other
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register